Patients with GBM overexpressing c-Met had a mTTP-2 of 3 months (95% CI 1.5–4.5) versus 7 months (95% CI 4.6–9.4) in patients with GBM with little or no expression of c-Met expression (Log-rank test, p = 0.050). Here, MET is linked to glioblastoma.